Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▼ |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -1.070% | 3.929% | 0.000% | -8.346% | -6.371% | 274.614% | 546.667% |
| Boston Scientific | 0.720% | 2.222% | 8.661% | 42.474% | 34.137% | 94.695% | 109.854% |
| Stryker Corp. | 0.200% | 1.051% | -4.796% | 18.895% | 14.047% | 46.944% | 85.272% |
| Merit Medical Systems | -1.360% | 4.255% | 10.526% | -4.545% | 8.088% | 38.679% | 47.650% |
| Bristol-Myers Squibb | 1.160% | 0.773% | -13.628% | -33.865% | -11.487% | -22.466% | -1.840% |
| Cardiff Oncology Inc. | -1.670% | -21.472% | -38.697% | 99.253% | 143.161% | -58.974% | -8.571% |
| Biocryst Pharmaceuticals | -0.190% | 17.761% | 10.978% | -37.158% | -11.222% | -54.425% | -29.238% |
| Novavax Inc. | 111.120% | -4.482% | 2.778% | -51.686% | -5.969% | -97.094% | -35.803% |
| Baxter International | -0.290% | -3.488% | -15.819% | -15.509% | -5.264% | -53.351% | -51.898% |
| Salarius Pharmaceuticals Inc. | 2.480% | -12.174% | -6.047% | -77.430% | -27.207% | -98.343% | -99.993% |
| Ardelyx Inc. | -3.250% | 19.664% | 14.204% | 98.895% | 30.761% | 36.180% | - |
| Rigel Pharmaceutical Inc. | -0.110% | -5.988% | -17.873% | -10.626% | -32.181% | -66.030% | - |
| Cytomx Therapeutics Inc | -17.190% | -47.768% | 14.950% | 38.953% | 55.874% | -67.858% | - |
| Fate Therapeutics Inc. | 5.540% | -5.579% | -41.534% | -26.474% | 1.378% | -94.276% | - |
| MacroGenics Inc. | -68.580% | -4.014% | -18.285% | 106.515% | 51.444% | -50.128% | - |
| Inogen Inc. | 2.610% | 22.901% | 12.587% | -20.297% | 51.887% | -85.364% | - |
| Radius Health Inc. | - | - | - | - | - | - | - |